This inventor holds 5 USPTO granted patents and 3 published patent applications and 3 EPO patents. Top assignees: Glaxosmithkline LLC, Cancer Research Technology Limited, Glaxosmithkline Intellectual Property Development Limited. Active years: 2012-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 358 
1 out of 268 
1 out of 242 
Years Active: 2012-2021
Title: The Innovative Contributions of Stanley J Schmidt
Introduction
Stanley J Schmidt is a notable inventor based in Collegeville, PA (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of 5 patents, his work primarily focuses on developing compounds that have the potential to treat various diseases, including cancer and autoimmune disorders.
Latest Patents
One of Schmidt's latest patents is titled "Substituted pyridines as inhibitors of DNMT1." This invention is directed to substituted pyridine derivatives, specifically compounds that are selective inhibitors of DNMT1. These compounds can be useful in treating cancer, pre-cancerous syndromes, and several blood disorders, including sickle cell disease and beta thalassemia. The invention also encompasses pharmaceutical compositions that include these compounds and methods for inhibiting DNMT1 activity.
Another significant patent is "Quinoline derivatives as PI3 kinase inhibitors." This invention outlines a method for inhibiting the activity of PI3 kinases using quinoline derivatives. The application of these derivatives extends to treating a range of diseases, such as autoimmune disorders, inflammatory diseases, and various forms of cancer.
Career Highlights
Throughout his career, Stanley J Schmidt has worked with prominent companies, including GlaxoSmithKline LLC and GlaxoSmithKline Intellectual Property Development Limited. His experience in these organizations has contributed to his expertise in pharmaceutical innovation and patent development.
Collaborations
Some of Schmidt's notable coworkers include Steven David Knight and Nicholas D Adams. Their collaborative efforts have likely played a role in advancing the research and development of the innovative compounds Schmidt has patented.
Conclusion
Stanley J Schmidt's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to addressing critical health issues. His work continues to influence the development of treatments for various diseases, showcasing the importance of innovation in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile